Kymera Therapeutics (KYMR) Enterprise Value (2020 - 2026)
Kymera Therapeutics (KYMR) posted Enterprise Value of $9.25 billion for Q3 2026, up 160.3% from $3.55 billion a year earlier and up 5.1% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Enterprise Value (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Enterprise Value came in at $5.48 billion, up 158.2% from FY2024.
- Annual Enterprise Value has increased for three consecutive years, with a five-year compound annual growth rate of 47.7% (FY2020 to FY2025).
- In prior years, Kymera Therapeutics' Enterprise Value was $2.12 billion in FY2024 (+104.0%), $1.04 billion in FY2023 (+7.6%), $966.62 million in FY2022 (-65.8%) and $2.83 billion in FY2021 (+263.0%).
- The Q3 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q3 2020.
- On a year-over-year basis, Enterprise Value has increased in each of the last six quarters, with growth averaging 143.5% over the last eight quarters.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q3 2024, with growth of 509.0%; the weakest was Q3 2022, with a decline of 71.3%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $8.8 billion (Q2 2026), $6.19 billion (Q1 2026) and $5.48 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.57 Bn |
| Jun 30, 2026 | 8.80 Bn |
| Mar 31, 2026 | 6.19 Bn |
| Dec 31, 2025 | 5.48 Bn |
| Sep 30, 2025 | 3.55 Bn |
| Jun 30, 2025 | 2.41 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 2.12 Bn |
| Sep 30, 2024 | 2.51 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.95 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 412.93 Mn |
| Jun 30, 2023 | 905.85 Mn |
| Mar 31, 2023 | 1.24 Bn |
| Dec 31, 2022 | 966.62 Mn |
| Sep 30, 2022 | 710.03 Mn |
| Jun 30, 2022 | 628.56 Mn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 2.83 Bn |
API Access
Kymera Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();